Gerl A - Search Results

1

ConTra Preference Language: Privacy Preference Unification via Privacy Interfaces.

Becher S, Gerl A. Becher S, et al. Among authors: gerl a. Sensors (Basel). 2022 Jul 20;22(14):5428. doi: 10.3390/s22145428. Sensors (Basel). 2022. PMID: 35891105 Free PMC article.

2

Layered Privacy Language Pseudonymization Extension for Health Care.

Gerl A, Bölz F. Gerl A, et al. Stud Health Technol Inform. 2019 Aug 21;264:1189-1193. doi: 10.3233/SHTI190414. Stud Health Technol Inform. 2019. PMID: 31438113

3

XACML for Mobility (XACML4M)-An Access Control Framework for Connected Vehicles.

Ashutosh A, Gerl A, Wagner S, Brunie L, Kosch H. Ashutosh A, et al. Among authors: gerl a. Sensors (Basel). 2023 Feb 4;23(4):1763. doi: 10.3390/s23041763. Sensors (Basel). 2023. PMID: 36850360 Free PMC article.

4

Screen Printing of pH-Responsive Dye to Textile.

Gorjanc M, Gerl A, Kert M. Gorjanc M, et al. Among authors: gerl a. Polymers (Basel). 2022 Jan 22;14(3):447. doi: 10.3390/polym14030447. Polymers (Basel). 2022. PMID: 35160437 Free PMC article.

5

Improved outcomes in metastatic germ cell cancer: results from a large cohort study.

Hentrich M, Debole J, Jurinovic V, Gerl A. Hentrich M, et al. Among authors: gerl a. J Cancer Res Clin Oncol. 2021 Feb;147(2):533-538. doi: 10.1007/s00432-020-03343-2. Epub 2020 Aug 9. J Cancer Res Clin Oncol. 2021. PMID: 32772232 Free PMC article.

6

The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).

Seidel C, Daugaard G, Tryakin A, Necchi A, Cohn-Cedermark G, Ståhl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Oing C, Bokemeyer C. Seidel C, et al. Among authors: gerl a. Urol Oncol. 2019 Nov;37(11):809.e19-809.e25. doi: 10.1016/j.urolonc.2019.07.020. Epub 2019 Sep 5. Urol Oncol. 2019. PMID: 31494007

7

Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors.

Seidel C, Daugaard G, Tryakin A, Necchi A, Cohn Cedermark G, Ståhl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Bokemeyer C. Seidel C, et al. Among authors: gerl a. Eur J Cancer. 2018 May;94:16-25. doi: 10.1016/j.ejca.2018.01.113. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29505967

8

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

International Prognostic Factors Study Group; Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. International Prognostic Factors Study Group, et al. J Clin Oncol. 2010 Nov 20;28(33):4906-11. doi: 10.1200/JCO.2009.26.8128. Epub 2010 Oct 18. J Clin Oncol. 2010. PMID: 20956623

9

Myocardial infarction and other major vascular events during chemotherapy for testicular cancer.

Dieckmann KP, Gerl A, Witt J, Hartmann JT; German Testicular Cancer Study Group. Dieckmann KP, et al. Among authors: gerl a. Ann Oncol. 2010 Aug;21(8):1607-1611. doi: 10.1093/annonc/mdp597. Epub 2010 Jan 12. Ann Oncol. 2010. PMID: 20067918 Free article.

10

Successful salvage high-dose chemotherapy and autologous stem-cell transplantation in HIV-related germ-cell tumor.

Hentrich M, Schiel X, Niedermeier A, Lutz L, Rupec R, Stief C, Bogner J, Karthaus M, Gerl A. Hentrich M, et al. Among authors: gerl a. Ann Oncol. 2009 Nov;20(11):1900-1. doi: 10.1093/annonc/mdp448. Epub 2009 Sep 11. Ann Oncol. 2009. PMID: 19748902 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page